BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Intellectual Property Office Decisions


You are here: BAILII >> Databases >> United Kingdom Intellectual Property Office Decisions >> RENERVEX (Trade Mark: Opposition) [2000] UKIntelP o04700 (16 February 2000)
URL: http://www.bailii.org/uk/cases/UKIntelP/2000/o04700.html
Cite as: [2000] UKIntelP o04700, [2000] UKIntelP o4700

[New search] [Printable PDF version] [Help]


RENERVEX (Trade Mark: Opposition) [2000] UKIntelP o04700 (16 February 2000)

For the whole decision click here: o04700

Trade mark decision

BL Number
O/047/00
Decision date
16 February 2000
Hearing officer
Dr W J Trott
Mark
RENERVEX
Classes
05
Applicants
Amgen Inc
Opponents
Bristol-Myers Squibb Company
Opposition
Sections 5(2)(b) & 5(4)(a)

Result

Section 5(2)(b) - Opposition failed

Section 5(4)(a) - Opposition failed

Points Of Interest

Summary

The opposition was based on the opponents’ earlier mark PRESERVEX, in Class 5. The Hearing Officer concluded that the marks were not sufficiently similar as to give rise to a likelihood of confusion. The possibility that the marks might be poorly reproduced, in use, could not form part of the Hearing Officer’s considerations, he found. The evidence of use did not support the case under passing off.



BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKIntelP/2000/o04700.html